Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (38 quarters reported)
$281M in Q2 2013 → $7.28M now. Hover for any quarter.
As reported for the quarter ended September 30, 2022. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Surrozen Inc | 97.0% | Unchanged | 3,497,500 | $7.07M |
| Surrozen Inc | 3.0% | Unchanged | 1,165,832 | $215K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2022 · filed November 14, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Silence Therapeutics PLC | Exited | −634,270 | −$7.52M | — |
| Compass Therapeutics Inc | Exited | −1,603,789 | −$4.22M | — |
| UT United Therapeutics Corp Del | Exited | −2,998 | −$706K | — |
| GM Globus Med Inc | Exited | −5,405 | −$303K | — |
| Tandem Diabetes Care Inc | Exited | −4,294 | −$254K | — |
quarter ended June 30, 2022 · filed August 15, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tandem Diabetes Care Inc | Trimmed | −143,033 | −$8.46M | 1.1% |
| GM Globus Med Inc | Trimmed | −101,619 | −$5.7M | 1.3% |
| UT United Therapeutics Corp Del | Trimmed | −21,565 | −$5.08M | 3.0% |
| Compass Therapeutics Inc | Trimmed | −1,896,211 | −$4.99M | 17.8% |
| HA Helix Acquisition Corp | Exited | −137,000 | −$1.52M | — |
| Silence Therapeutics PLC | Trimmed | −19,838 | −$235K | 31.7% |
quarter ended March 31, 2022 · filed May 16, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| GM Globus Med Inc | Trimmed | −266,230 | −$19.6M | 13.4% |
| Tandem Diabetes Care Inc | Trimmed | −153,337 | −$17.8M | 29.1% |
| UT United Therapeutics Corp Del | Trimmed | −35,275 | −$6.33M | 7.5% |
| JA Jiya Acquisition Corp | Exited | −300,000 | −$2.93M | — |
| RA Research Alliance Corp Ii | Exited | −300,000 | −$2.93M | — |
| MS Medicus Sciences Acquisition | Exited | −300,000 | −$2.92M | — |
| AS Arya Sciences Acquisitn Corp | Exited | −300,000 | −$2.91M | — |
| Silence Therapeutics PLC | Trimmed | −104,145 | −$1.98M | 21.1% |
| PA Panacea Acquisition Corp Ii | Exited | −200,000 | −$1.94M | — |
| HA Helix Acquisition Corp | Trimmed | −13,000 | −$144K | 2.6% |
Showing the 10 largest of 12 changes.
quarter ended December 31, 2021 · filed February 14, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tandem Diabetes Care Inc | Trimmed | −186,663 | −$28.1M | 29.5% |
| UT United Therapeutics Corp Del | Trimmed | −98,000 | −$21.2M | 8.4% |
| Springworks Therapeutics Inc | Exited | −305,994 | −$19.4M | — |
| Surrozen Inc | Added | +2,497,500 | +$16M | 14.6% |
| GM Globus Med Inc | Trimmed | −215,846 | −$15.6M | 17.6% |
| Silence Therapeutics PLC | Added | +579,466 | +$13.8M | 11.8% |
| Compass Therapeutics Inc | New | +3,500,000 | +$11.2M | 7.3% |
| OH Olink Hldg Ab | Exited | −115,425 | −$2.8M | — |
| Casi Pharmaceuticals Inc | Exited | −1,563,003 | −$1.86M | — |
| Surrozen Inc | Added | +832,499 | +$950K | 0.9% |
quarter ended September 30, 2021 · filed November 15, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Protagonist Therapeutics Inc | Exited | −3,446,874 | −$155M | — |
| Legend Biotech Corp | Exited | −1,647,497 | −$67.6M | — |
| Tandem Diabetes Care Inc | Trimmed | −491,899 | −$58.7M | 31.8% |
| Springworks Therapeutics Inc | Trimmed | −893,345 | −$56.7M | 10.6% |
| Verastem Inc | Exited | −13,600,014 | −$55.4M | — |
| GM Globus Med Inc | Trimmed | −495,879 | −$38M | 24.7% |
| Keros Therapeutics Inc | Exited | −887,885 | −$37.7M | — |
| Sarepta Therapeutics Inc | Exited | −409,301 | −$31.8M | — |
| Affimed N V | Exited | −3,176,418 | −$27M | — |
| GC Gamida Cell Ltd | Exited | −2,858,558 | −$18.3M | — |
Showing the 10 largest of 29 changes.
quarter ended June 30, 2021 · filed August 16, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tandem Diabetes Care Inc | New | +979,226 | +$95.4M | 11.5% |
| Macrogenics Inc | Exited | −2,472,447 | −$78.7M | — |
| UT United Therapeutics Corp Del | Trimmed | −399,075 | −$71.6M | 3.4% |
| Mirati Therapeutics Inc | Exited | −255,203 | −$43.7M | — |
| TP Turning Point Therapeutics I | Exited | −450,396 | −$42.6M | — |
| GM Globus Med Inc | Added | +506,608 | +$39.3M | 10.1% |
| Protagonist Therapeutics Inc | Added | +737,165 | +$33.1M | 18.6% |
| Sarepta Therapeutics Inc | New | +409,301 | +$31.8M | 3.8% |
| Legend Biotech Corp | Added | +750,889 | +$30.8M | 8.1% |
| Arvinas Inc | Exited | −460,000 | −$30.4M | — |
Showing the 10 largest of 36 changes.
quarter ended March 31, 2021 · filed May 17, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| TT Tcr2 Therapeutics Inc | Exited | −584,885 | −$71.3M | — |
| GD Genmark Diagnostics Inc | Exited | −4,480,163 | −$65.4M | — |
| Affimed N V | New | +6,008,974 | +$47.5M | 5.1% |
| TP Turning Point Therapeutics I | New | +450,396 | +$42.6M | 4.5% |
| Mersana Therapeutics Inc | Exited | −1,401,703 | −$37.3M | — |
| KH Kadmon Hldgs Inc | Exited | −7,349,621 | −$30.5M | — |
| Iovance Biotherapeutics Inc | Trimmed | −920,606 | −$29.1M | 2.7% |
| Agios Pharmaceuticals Inc | Exited | −631,215 | −$27.4M | — |
| Atara Biotherapeutics Inc | Trimmed | −1,863,445 | −$26.8M | 2.6% |
| Legend Biotech Corp | New | +896,608 | +$26M | 2.8% |
Showing the 10 largest of 42 changes.
quarter ended December 31, 2020 · filed February 16, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| TT Tcr2 Therapeutics Inc | Trimmed | −924,934 | −$113M | 6.7% |
| UT United Therapeutics Corp Del | New | +528,964 | +$80.3M | 7.5% |
| Iovance Biotherapeutics Inc | New | +1,710,803 | +$79.4M | 7.4% |
| Mirati Therapeutics Inc | New | +330,000 | +$72.5M | 6.8% |
| GM Globus Med Inc | New | +908,953 | +$59.3M | 5.5% |
| Mersana Therapeutics Inc | Trimmed | −2,066,468 | −$55M | 3.5% |
| Aptose Biosciences Inc | Exited | −7,994,904 | −$48M | — |
| Compugen Ltd | Exited | −2,637,421 | −$42.9M | — |
| Keros Therapeutics Inc | New | +557,095 | +$39.3M | 3.7% |
| KP Kiniksa Pharmaceuticals Ltd | Exited | −2,374,392 | −$36.4M | — |
Showing the 10 largest of 42 changes.
Loading...
